Any Covid-19 vaccine? All nations and the entire world humanity was eagerly awaiting the precious announcement from at least one top nation that its scientists have successfully completed clinical trials of Covid-19 vaccine.
When expectations were running high that it would be China, where the novel coronavirus had its origin in the city of Wuhan, unexpectedly Russia has announced first to the world that its clinical trials are completed successfully and the vaccine is ready for production.
The Sechenov First Moscow State Medical University is the one which has claimed that it has successfully completed the trails their vaccine has all the “safety of those vaccines that are currently in the market.”
Announcing the news, Vadim Tarasov, the director of the Institute for Translational Medicine and Biotechnology of the Unviersity said the clinical trials have been conducted on volunteers, reports Russian news agency Sputnik, adding that the first group of volunteers would be discharged on 15 July and the second on 20 July.
The vaccine was produced by Russia’s Gamalei Institute of Epidemiology and Microbiology on June 18. “Sechenov University has successfully completed tests on volunteers of the world’s first vaccine against coronavirus,” Tarasov said.
“The safety of the vaccine is confirmed. It corresponds to the safety of those vaccines that are currently on the market,” said another scientist Alexander Lukashev, director of the Institute of Medical Parasitology, Tropical and Vector-Borne Diseases at Sechenov University.
“Sechenov University in a pandemic situation acted not only as an educational institution but also as a scientific and technological research center that is able to participate in the creation of such important and complex products as drugs,” Tarasov said.
Elsewhere, Gilead Sciences, Oxford University’s researchers and American biotech company Moderna are at the forefront of developing a Covid-19 vaccine, while a Canadian and Chinese joint project is equally pushing the date for completion of clinical trials. BioNTech SE and Pfizer Inc’s Covid-19 vaccine candidate is expected to be ready by the end of 2020.
Courtesy – indiainternationaltime